Azelnidipine/Telmisartan

阿折地平/替米沙坦

Report date: 2022/02/11 15:02:35

Base Information

Drug NameAzelnidipine/Telmisartan
Drug Alias NameAzelnidipine/telmisartan - Synokem PharmaceuticalsTelmisartan/azelnidipine - Synokem Pharmaceuticals
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated L-type calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated L-type calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes AzelnidipineTelmisartan
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesSynokem Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSynokem Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A